SCPHARMACEUTICALS INC. Deferred Tax Assets, Valuation Allowance
SCPHARMACEUTICALS INC. had Deferred Tax Assets, Valuation Allowance of $94.09 million as of 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2025-03-19
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $94.09M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $73.16M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $59.09M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $51.40M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2024-12-31 | $94.09M 10-K · filed 2025-03-19 |
| 2023-12-31 | $73.16M 10-K · filed 2025-03-19 |
| 2022-12-31 | $59.09M 10-K · filed 2025-03-19 |
| 2021-12-31 | $51.40M 10-K · filed 2024-03-13 |
| 2020-12-31 | $43.08M 10-K · filed 2022-03-22 |
| 2019-12-31 | $34.00M 10-K · filed 2021-03-23 |
| 2018-12-31 | $24.71M 10-K · filed 2020-03-24 |
| 2017-12-31 | $16.65M 10-K · filed 2019-03-21 |